Please use this identifier to cite or link to this item: http://hdl.handle.net/10668/807
Title: Primary renal lymphoma: long-term results of two patients treated with a chemotherapy + rituximab protocol.
Authors: Vázquez-Alonso, F
Puche-Sanz, I
Sánchez-Ramos, C
Flores-Martín, J
Vicente-Prados, J
Cózar-Olmo, J M
metadata.dc.contributor.authoraffiliation: [Vázquez-Alonso,F; Puche-Sanz,I; Flores-Martín,J; Vicente-Prados,J; Cózar-Olmo,JM] Department of Urology, Hospital Universitario Virgen de las Nieves, Granada, Spain. [Sánchez-Ramos,C] Department of Hematology, Hospital Universitario Virgen de las Nieves, Granada, Spain.
Keywords: Linfoma;Antineoplastic Agents;rituximab;Antineoplásicos;Anticuerpos Monoclonales;Ciclofosfamida;Doxorrubicina;Vincristina;Prednisolona;R-CHOP protocol;Neoplasias Renales
metadata.dc.subject.mesh: Medical Subject Headings::Diseases::Neoplasms::Neoplasms by Histologic Type::Lymphoma
Medical Subject Headings::Chemicals and Drugs::Amino Acids, Peptides, and Proteins::Proteins::Blood Proteins::Immunoproteins::Immunoglobulins::Antibodies::Antibodies, Monoclonal
Medical Subject Headings::Chemicals and Drugs::Chemical Actions and Uses::Pharmacologic Actions::Therapeutic Uses::Antineoplastic Agents
Medical Subject Headings::Chemicals and Drugs::Organic Chemicals::Hydrocarbons::Hydrocarbons, Halogenated::Mustard Compounds::Nitrogen Mustard Compounds::Phosphoramide Mustards::Cyclophosphamide
Medical Subject Headings::Chemicals and Drugs::Organic Chemicals::Hydrocarbons::Hydrocarbons, Cyclic::Hydrocarbons, Aromatic::Polycyclic Hydrocarbons, Aromatic::Naphthacenes::Anthracyclines::Daunorubicin::Doxorubicin
Medical Subject Headings::Chemicals and Drugs::Heterocyclic Compounds::Alkaloids::Indole Alkaloids::Secologanin Tryptamine Alkaloids::Vinca Alkaloids::Vincristine
Medical Subject Headings::Chemicals and Drugs::Polycyclic Compounds::Steroids::Pregnanes::Pregnadienes::Pregnadienetriols::Prednisolone
Medical Subject Headings::Diseases::Neoplasms::Neoplasms by Site::Urogenital Neoplasms::Urologic Neoplasms::Kidney Neoplasms
Issue Date: 22-Aug-2012
Publisher: Hindawi Publishing Corporation
Citation: Vázquez-Alonso F, Puche-Sanz I, Sánchez-Ramos C, Flores-Martín J, Vicente-Prados J, Cózar-Olmo JM. Primary renal lymphoma: long-term results of two patients treated with a chemotherapy + rituximab protocol. Case Rep Oncol Med; 2012:726424
Abstract: Primary renal lymphoma (PRL) is a rare disease of which the etiology and pathogenesis remain controversial, and there is currently no standard treatment for it. We present the results of a long-term followup of two patients who were diagnosed with PRL and treated with cyclophosphamide, adriamycin, vincristine, prednisolone and rituximab (CHOP + R) regimen. Both patients reached a complete response, and there is no evidence of recurrence after 4.5- and 5-year followup periods. Based on our experience and other recently published studies, we recommend the combination of CHOP + rituximab as the elective treatment for this disease. To our knowledge, this is the longest followup period with a complete response that has been reported with this modality of treatment.
Description: Journal Article;
URI: http://hdl.handle.net/10668/807
metadata.dc.relation.publisherversion: http://www.hindawi.com/crim/oncmed/2012/726424/
metadata.dc.identifier.doi: 10.1155/2012/726424
ISSN: 2090-6714 (Online)
Appears in Collections:01- Artículos - Hospital Virgen de las Nieves

Files in This Item:
File Description SizeFormat 
Vazque-Alonso_PrimaryRenalLymphoma.pdf894,96 kBAdobe PDFView/Open


This item is protected by original copyright



This item is licensed under a Creative Commons License Creative Commons